Position in ALNY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$310,708,106
-$21,048,949 QoQ
Shares Held
1,032,150
+2.9% QoQ
Ownership
0.771%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#22
of 780 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 76%
Shared 0%
None 24%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,717,847,277 across 523 Biotechnology names. ALNY ranks #9 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in ALNY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $310,708,106 | 1,032,150 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $331,757,055 | 1,002,681 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $385,782,924 | 970,157 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $331,083,816 | 726,061 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $251,404,951 | 770,968 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $173,289,381 | 641,765 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $171,123,072 | 727,224 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $170,123,376 | 618,563 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $180,187,902 | 741,514 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $100,920,737 | 675,281 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $154,390,341 | 806,595 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $214,181,724 | 1,209,383 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $357,240,285 | 1,880,806 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $246,556,854 | 1,230,815 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $330,485,591 | 1,390,640 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $299,991,597 | 1,498,759 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $164,608,494 | 1,128,615 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $138,577,198 | 848,657 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $180,719,536 | 1,065,689 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $355,128,760 | 1,880,879 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $319,146,993 | 1,882,651 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $252,158,841 | 1,785,954 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $219,888,439 | 1,691,840 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $221,362,955 | 1,520,350 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $223,626,990 | 1,509,871 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $150,779,017 | 1,385,200 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||